Cargando…
H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer and Demonstrates Utility as a Prognostic Biomarker in Terms of Overall Survival
Background: H2AX can be of prognostic value in breast cancer, since in advanced stage patients with high levels, there was an association with worse overall survival (OS). However, the clinical relevance of H2AX in ovarian cancer (OC) remains to be elucidated. Methods: OC H2AX expression studied usi...
Autores principales: | Saravi, Sayeh, Katsuta, Eriko, Jeyaneethi, Jeyarooban, Amin, Hasnat A., Kaspar, Matthias, Takabe, Kazuaki, Pados, George, Drenos, Fotios, Hall, Marcia, Karteris, Emmanouil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565050/ https://www.ncbi.nlm.nih.gov/pubmed/32887437 http://dx.doi.org/10.3390/jcm9092844 |
Ejemplares similares
-
A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer
por: Kerslake, Rachel, et al.
Publicado: (2021) -
Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers
por: Chudasama, Dimple, et al.
Publicado: (2018) -
Identification of Cancer-Associated Circulating Cells in Anal Cancer Patients
por: Carter, Thomas J., et al.
Publicado: (2020) -
Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer
por: Zahra, Aeman, et al.
Publicado: (2021) -
Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry
por: Rogers-Broadway, Karly-Rai, et al.
Publicado: (2019)